These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36875078)

  • 1. Subtyping based on immune cell fractions reveal heterogeneity of cardiac fibrosis in end-stage heart failure.
    Zou S; Khoo BL
    Front Immunol; 2023; 14():1053793. PubMed ID: 36875078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding insult to injury - Inflammation at the heart of cardiac fibrosis.
    Smolgovsky S; Ibeh U; Tamayo TP; Alcaide P
    Cell Signal; 2021 Jan; 77():109828. PubMed ID: 33166625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
    Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
    J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis and heart failure.
    Segura AM; Frazier OH; Buja LM
    Heart Fail Rev; 2014 Mar; 19(2):173-85. PubMed ID: 23124941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac dysfunction after preeclampsia; an overview of pro- and anti-fibrotic circulating effector molecules.
    Mohseni Z; Derksen E; Oben J; Al-Nasiry S; Spaanderman MEA; Ghossein-Doha C
    Pregnancy Hypertens; 2021 Mar; 23():140-154. PubMed ID: 33388730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.
    Nural-Guvener H; Zakharova L; Feehery L; Sljukic S; Gaballa M
    Int J Mol Sci; 2015 May; 16(5):11482-99. PubMed ID: 25997003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.
    de Boer RA; De Keulenaer G; Bauersachs J; Brutsaert D; Cleland JG; Diez J; Du XJ; Ford P; Heinzel FR; Lipson KE; McDonagh T; Lopez-Andres N; Lunde IG; Lyon AR; Pollesello P; Prasad SK; Tocchetti CG; Mayr M; Sluijter JPG; Thum T; Tschöpe C; Zannad F; Zimmermann WH; Ruschitzka F; Filippatos G; Lindsey ML; Maack C; Heymans S
    Eur J Heart Fail; 2019 Mar; 21(3):272-285. PubMed ID: 30714667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
    Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
    Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
    Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
    Ichiki T; Schirger JA; Huntley BK; Brozovich FV; Maleszewski JJ; Sandberg SM; Sangaralingham SJ; Park SJ; Burnett JC
    J Mol Cell Cardiol; 2014 Oct; 75():199-205. PubMed ID: 25117468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis.
    Ferreira JP; Machu JL; Girerd N; Jaisser F; Thum T; Butler J; González A; Diez J; Heymans S; McDonald K; Gyöngyösi M; Firat H; Rossignol P; Pizard A; Zannad F
    ESC Heart Fail; 2018 Feb; 5(1):139-148. PubMed ID: 28988439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
    Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
    J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Network-Based "Phenomics" Approach for Discovering Patient Subtypes From High-Throughput Cardiac Imaging Data.
    Cho JS; Shrestha S; Kagiyama N; Hu L; Ghaffar YA; Casaclang-Verzosa G; Zeb I; Sengupta PP
    JACC Cardiovasc Imaging; 2020 Aug; 13(8):1655-1670. PubMed ID: 32762883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocytes facing fibrotic conditions re-express extracellular matrix transcripts.
    Heras-Bautista CO; Mikhael N; Lam J; Shinde V; Katsen-Globa A; Dieluweit S; Molcanyi M; Uvarov V; Jütten P; Sahito RGA; Mederos-Henry F; Piechot A; Brockmeier K; Hescheler J; Sachinidis A; Pfannkuche K
    Acta Biomater; 2019 Apr; 89():180-192. PubMed ID: 30862552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of energy metabolism-related biomarkers for risk prediction of heart failure patients using random forest algorithm.
    Chen H; Jiang R; Huang W; Chen K; Zeng R; Wu H; Yang Q; Guo K; Li J; Wei R; Liao S; Tse HF; Sha W; Zhuo Z
    Front Cardiovasc Med; 2022; 9():993142. PubMed ID: 36304554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.
    Farris SD; Don C; Helterline D; Costa C; Plummer T; Steffes S; Mahr C; Mokadam NA; Stempien-Otero A
    J Am Coll Cardiol; 2017 Jul; 70(3):344-354. PubMed ID: 28705316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.